First Mercantile Trust’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $40K | Hold |
680
| – | – | 0.01% | 790 |
|
|
2021
Q2 | $59K | Sell |
680
-83
| -11% | -$7.2K | 0.01% | 779 |
|
|
2021
Q1 | $63K | Sell |
763
-131
| -15% | -$10.8K | 0.01% | 761 |
|
|
2020
Q4 | $81K | Buy |
+894
| New | +$81K | 0.01% | 731 |
|
|
2020
Q2 | – | Sell |
-5,700
| Closed | -$127K | – | 887 |
|
|
2020
Q1 | $127K | Sell |
5,700
-250
| -4% | -$5.57K | 0.02% | 487 |
|
|
2019
Q4 | $116K | Sell |
5,950
-8,575
| -59% | -$167K | 0.01% | 637 |
|
|
2019
Q3 | $226K | Sell |
14,525
-10
| -0.1% | -$156 | 0.02% | 448 |
|
|
2019
Q2 | $295K | Buy |
14,535
+73
| +0.5% | +$1.48K | 0.03% | 320 |
|
|
2019
Q1 | $254K | Sell |
14,462
-665
| -4% | -$11.7K | 0.06% | 377 |
|
|
2018
Q4 | $194K | Sell |
15,127
-2,307
| -13% | -$29.6K | 0.05% | 436 |
|
|
2018
Q3 | $284K | Buy |
17,434
+4,535
| +35% | +$73.9K | 0.06% | 391 |
|
|
2018
Q2 | $146K | Buy |
12,899
+6,863
| +114% | +$77.7K | 0.03% | 606 |
|
|
2018
Q1 | $59K | Buy |
+6,036
| New | +$59K | 0.01% | 727 |
|